000 | 01943 a2200577 4500 | ||
---|---|---|---|
005 | 20250517075928.0 | ||
264 | 0 | _c20170109 | |
008 | 201701s 0 0 eng d | ||
022 | _a1949-2553 | ||
024 | 7 |
_a10.18632/oncotarget.7082 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aOnuma, Wakana | |
245 | 0 | 0 |
_aIrsogladine maleate, a gastric mucosal protectant, suppresses intestinal polyp development in Apc-mutant mice. _h[electronic resource] |
260 |
_bOncotarget _cFeb 2016 |
||
300 |
_a8640-52 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Ulcer Agents _xpharmacology |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 | _aBlotting, Western |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aGastric Mucosa _xdrug effects |
650 | 0 | 4 |
_aGenes, APC _xphysiology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunoenzyme Techniques |
650 | 0 | 4 |
_aInterleukin-1beta _xgenetics |
650 | 0 | 4 |
_aInterleukin-6 _xgenetics |
650 | 0 | 4 |
_aIntestinal Polyps _xpathology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 |
_aMutation _xgenetics |
650 | 0 | 4 |
_aRNA, Messenger _xgenetics |
650 | 0 | 4 | _aReal-Time Polymerase Chain Reaction |
650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 |
_aTriazines _xpharmacology |
700 | 1 | _aTomono, Susumu | |
700 | 1 | _aMiyamoto, Shinngo | |
700 | 1 | _aFujii, Gen | |
700 | 1 | _aHamoya, Takahiro | |
700 | 1 | _aFujimoto, Kyoko | |
700 | 1 | _aMiyoshi, Noriyuki | |
700 | 1 | _aFukai, Fumio | |
700 | 1 | _aWakabayashi, Keiji | |
700 | 1 | _aMutoh, Michihiro | |
773 | 0 |
_tOncotarget _gvol. 7 _gno. 8 _gp. 8640-52 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.18632/oncotarget.7082 _zAvailable from publisher's website |
999 |
_c25697615 _d25697615 |